Director Eric Stanton Weiss increased his stake in Core Scientific by 7,000 shares, reinforcing bullish sentiment as analysts project a potential 92% upside for the blockchain infrastructure firm.
Core Scientific director Eric Stanton Weiss recently demonstrated strong internal confidence by purchasing 7,000 shares of common stock at a weighted average price of $19.19. This insider buying, combined with a 94% 'buy' rating from analysts and a median price target of $36, suggests significant upside potential despite the company's current net loss of $1.6 billion. The stock has outperformed the S&P 500 over the past year, climbing 34.4% compared to the index's 18.1% gain.
Following the purchase of 7,000 shares, Eric Stanton Weiss directly holds 259,262 shares, representing an 0.08% ownership interest.
The company generates revenue through two primary channels: proprietary digital asset mining in its own data centers and providing colocation services for third-party blockchain network participants.
Core Scientific Director Eric Stanton Weiss purchased 7,000 shares of common stock on August 18, 2026, at a weighted average price of $19.19. This insider acquisition, totaling $134,330, signals internal confidence in the digital asset miner, which has seen its stock climb 34.4% over the past year.
Insider buying, particularly during a period of rising stock prices, is generally viewed as a bullish signal indicating that company leadership expects further appreciation in the stock's value.
Market sentiment is highly positive, with 94% of analysts covering the stock issuing a 'buy' rating and a median one-year price target of $36.